Results 151 to 160 of about 11,560 (188)
Some of the next articles are maybe not open access.
Fractional Exhaled Nitric Oxide in Clinical Trials: An Overview
2013Designing clinical trials in asthma it is crucial to find the perfect primary endpoint for showing bioequivalence, especially when the investigational medicinal product is not a bronchodilator, but a substance, which suppresses the inflammatory process, e.g. inhalative corticosteroids (ICS).
Sabine, Häussermann +3 more
openaire +2 more sources
The Use of Fraction of Exhaled Nitric Oxide in Pulmonary Practice
Chest, 2008The measurement of the fractional concentration of exhaled nitric oxide (FeNO) is a convenient, noninvasive, point-of-service office test for airway inflammation. The first half of this practice management review presents the methodological, interpretative, and clinical applications of FeNO.
Kaiser G, Lim, Carl, Mottram
openaire +2 more sources
Immunotherapy, 2022
Checkpoint inhibitor pneumonitis (CIP) is a relatively rare adverse event and a potential cause of death in patients treated with immune checkpoint inhibitors (ICIs).
Chen-Wei Wu +7 more
semanticscholar +1 more source
Checkpoint inhibitor pneumonitis (CIP) is a relatively rare adverse event and a potential cause of death in patients treated with immune checkpoint inhibitors (ICIs).
Chen-Wei Wu +7 more
semanticscholar +1 more source
Respiratory Investigation, 2020
Nitric oxide (NO) is produced in the body and has been shown to have diverse actions in the abundance of research that has been performed on it since the 1970s, leading to Furchgott, Murad, and Ignarro receiving the Nobel Prize in Physiology or Medicine ...
K. Matsunaga +8 more
semanticscholar +1 more source
Nitric oxide (NO) is produced in the body and has been shown to have diverse actions in the abundance of research that has been performed on it since the 1970s, leading to Furchgott, Murad, and Ignarro receiving the Nobel Prize in Physiology or Medicine ...
K. Matsunaga +8 more
semanticscholar +1 more source
American Journal of Rhinology & Allergy, 2022
Purpose Nitric oxide (NO) is a potential marker in the diagnosis and monitoring of treatment for the management of patients with allergic rhinitis (AR).
Aishah Harizah Abdullah Alwi +4 more
semanticscholar +1 more source
Purpose Nitric oxide (NO) is a potential marker in the diagnosis and monitoring of treatment for the management of patients with allergic rhinitis (AR).
Aishah Harizah Abdullah Alwi +4 more
semanticscholar +1 more source
Fractional exhaled nitric oxide and nasal nitric oxide as biomarkers in chronic rhinosinusitis
Current Opinion in Allergy & Clinical ImmunologyPurpose of review This article summarizes current evidence on the role of fractional exhaled nitric oxide (FeNO) and nasal nitric oxide (nNO) as noninvasive biomarkers in chronic rhinosinusitis with nasal polyps (CRSwNP), focusing on their potential to refine endotype-driven diagnosis and monitoring in the ...
Alessandro, Solinas +4 more
openaire +2 more sources
The Role of Fractional Exhaled Nitric Oxide in Asthma Management
Otolaryngologic Clinics of North America, 2014Measuring fractional exhaled nitric oxide (FeNO) is a relatively new option for assessing allergic inflammation in the lungs. Clinical management of asthma is challenging, and measuring exhaled nitric oxide can provide another type of data to assist in meeting this challenge.
openaire +2 more sources
Fractional exhaled nitric oxide in pulmonary hypertension
4.3 Pulmonary Circulation and Pulmonary Vascular Diseases, 2016Introduction: Decreased nitric oxide (NO) availability is implicated in the pathogenesis of pulmonary arterial hypertension (PAH). Prior studies found low fractional exhaled NO (FeNO) in idiopathic PAH (IPAH) and scleroderma-related PAH (SSc-PAH) patients. Comparison among different forms of PH has not been reported. Aims: Compare FeNO levels among
Hala El Chami +5 more
openaire +1 more source
Relationship between fractional exhaled nitric oxide and nasal nitric oxide in airways disease
Annals of Allergy, Asthma & Immunology, 2010Invasive techniques show evidence of a unified allergic airway. Nitric oxide is measured noninvasively from the lungs (fractional exhaled nitric oxide [FeNO]) and nose (nasal nitric oxide [nNO]).To investigate the relationship between FeNO and nNO in different airway conditions.A total of 227 participants were assessed: 41 healthy volunteers (HVs), 33 ...
Williamson, Peter A. +4 more
openaire +3 more sources
Fractional Exhaled Nitric Oxide: Indications and Interpretation
2014Exhaled nitric oxide (NO) is a marker for eosinophilic airway inflammation. The correlations between fraction of exhaled NO (FENO) and eosinophils in blood, sputum, bronchoalveolar lavage, and mucosal biopsies of the airway have been well studied. A quantitative, noninvasive, and simple methodology has been developed to determine how best to assess ...
Young-Jee Kim +2 more
openaire +1 more source

